Novel mechanism of the vascular protector prostacyclin: regulating microRNA expression

Anita Mohite1, Annirudha Chillar, Shui-Ping So

  • 1Center for Experimental Therapeutics and PharmacoInformatics and Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77004, United States.

Biochemistry
|January 22, 2011
PubMed

Insights

Prostacyclin (PGI(2)) regulates microRNA (miRNA) expression via its receptors. This study demonstrates PGI(2) influences lipid deposition in adipocytes, suggesting a role in various diseases.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Vascular Biology

Background:

  • Prostacyclin (PGI(2)) is a crucial vascular protector derived from arachidonic acid (AA).
  • PGI(2) exerts its effects through the prostacyclin receptor (IP) and peroxisome proliferator-activated receptor gamma (PPARγ).

Purpose of the Study:

  • To investigate the role of PGI(2) in regulating microRNA (miRNA) expression.
  • To explore the impact of PGI(2)-mediated miRNA changes on adipocyte function and lipid deposition.

Main Methods:

  • Utilized a novel hybrid enzyme (COX-1-10aa-PGIS) to achieve stable, dominant PGI(2) production in mouse adipose-derived cells.
  • Conducted miRNA microarray analysis to identify differentially expressed miRNAs.
  • Administered IP and PPARγ receptor antagonists to assess their effect on miRNA expression.
  • Investigated the effect of PGI(2) upregulation on insulin-mediated lipid deposition in adipocytes.

Main Results:

  • Upregulation of PGI(2) significantly altered the expression of specific miRNAs (711, 148b, 744).
  • These miRNA changes were reversible with IP and PPARγ receptor antagonists.
  • Increased PGI(2) levels inhibited insulin-mediated lipid deposition in adipocytes.
  • A potential mechanism involving miRNA-mediated gene expression inhibition was proposed.

Conclusions:

  • PGI(2) regulates cellular miRNA expression through IP and PPARγ receptors.
  • PGI(2)-miRNA interactions may play a role in inhibiting lipid deposition in adipocytes.
  • This PGI(2)-miRNA regulatory axis could be relevant in pathophysiological processes including apoptosis, vascular inflammation, cancer, embryo implantation, and obesity.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...